Nanosensors target enzymes to monitor and study cancer
By analyzing enzyme activity at the organism, tissue, and cellular scales, new sensors could provide new tools to clinicians and cancer researchers.
Angela Koehler takes on the most challenging drug targets
Using biological, chemical, and engineering tools, she has developed strategies to attack molecules once thought to be “undruggable.”
Today’s postdocs, tomorrow’s mentors
At luncheon, Vice President for Research Maria Zuber and others express appreciation for the Institute’s postdoctoral researchers; new postdoc mentoring award debuts.
Four from MIT receive NIH New Innovator Awards for 2022
Awards support high-risk, high-impact research from early-career investigators.
Breaking through the mucus barrier
A capsule that tunnels through mucus in the GI tract could be used to orally administer large protein drugs such as insulin.
MIT biologist Richard Hynes wins Lasker Award
Hynes and two other scientists will share the prize for their discoveries of proteins critical for cellular adhesion.
A “golden era” to study the brain
“We can’t think of the brain only as neurons,” says PhD student Mitch Murdock, who explores the cellular basis of Alzheimer’s disease.
Using machine learning to identify undiagnosable cancers
A new model that maps developmental pathways to tumor cells may unlock the identity of cancers of unknown primary.
Microscopy technique reveals hidden nanostructures in cells and tissues
Separating densely packed molecules before imaging allows them to become visible for the first time.
Amy Keating named head of the Department of Biology
The computational structural biology researcher continues to serve the department and the MIT life sciences community.
New test may predict Covid-19 immunity
The paper test measures the level of neutralizing antibodies in a blood sample and could help people decide what protections they should take against infection.
How different cancer cells respond to drug-delivering nanoparticles
The findings of a large-scale screen could help researchers design nanoparticles that target specific types of cancer.
When cells’ tiny differences have far-reaching implications
Alex Shalek’s technologies for single-cell RNA profiling can help dissect the cellular bases of complex diseases around the globe.
Microparticles could be used to deliver “self-boosting” vaccines
With particles that release their payloads at different times, one injection could provide multiple vaccine doses.
Tissue model reveals key players in liver regeneration
By tracing the steps of liver regrowth, MIT engineers hope to harness the liver’s regenerative abilities to help treat chronic disease.